Clinical study impact of dabigatran versus phenprocoumon on adp induced platelet aggregation in patients with atrial fibrillation with or without concomitant clopidogrel therapy (the dabi-adp-1 and dabi-adp-2 trials)

HIGHLIGHTS

• who: Amadea M. Martischnig et al. from the Deutsches Herzzentrum Muu0308nchen, Technische Universitau0308t Muu0308nchen, Munich, Germany have published the paper: Clinical Study Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials), in the Journal: (JOURNAL) of 17/Dec/2014
• what: The trial does not answer whether platelet function may have been affected between baseline and at two weeks when the primary endpoint was assessed.
• how: The studies were conducted in accordance with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.